Zhao Yan New Drugs (603127.SH): The company's stock price has seen a significant increase in the short term, with risks of market sentiment overheating and irrational speculation.

Zhixin finance and economics APP news, Zhaoyan Pharmaceutical (603127.SH) issued a price abnormality announcement, the company's stock closed price has deviated by more than 20% from the cumulative value for three consecutive trading days on July 14, July 15, and July 16, 2026. The company's stock has a large short-term increase, there is a risk of market sentiment being overheated and speculative trading being irrational, and there is a great trading risk, with the risk of a stock price decline at any time. In addition, the fair value of the company's biological assets is influenced by various uncertain factors, posing a significant risk of value fluctuation. We kindly remind investors to pay attention to the trading risks in the secondary market, make rational decisions, and invest prudently.